Life Sciences & Pharma • Executive Insights Biopharma Launch Trends — Lessons Learned From L.E.K.’s Launch Monitor December 18, 2020 The cost of drug development continues to rise and the probability of creating new blockbuster therapies is not getting any easier.
Healthcare Services • Published Articles Exclusive Interview: Helen Chen, Global Leader in Healthcare Consulting October 15, 2020 Learn more about L.E.K.'s Helen Chen in this interview with myBioGate.
Life Sciences & Pharma • Executive Insights Approaching Japan’s Increasingly Challenging and Subjective Drug Pricing Environment November 17, 2020 Companies need to understand Japan’s pricing system and anticipate and plan for potential challenges both in advance of and subsequent to launch.
Life Sciences & Pharma • Video / Webinar Webinar Recording: Using Real-World Data to Optimize Pharma Pricing in China November 24, 2020 In this webinar, we share perspectives on the application of real-world data in pharma pricing and other sectors within healthcare.
Life Sciences & Pharma • Presentations 2021 Asia-Pacific (APAC) Digital Readiness for the Healthcare Sector February 26, 2021 The digital health landscape is transforming rapidly; L.E.K. Consulting and Galen Growth evaluated APAC countries.
Healthcare Services • Published Articles Delivering Healthcare at the Touch of a Button September 10, 2021
